Clinical Trials in Xining, China
6 recruiting
Showing 1–20 of 40 trials
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer (Early Breast Cancer)
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Phase 3
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.500 enrolled224 locationsNCT06901531
Recruiting
Phase 3
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy, Chemotherapy-induced
Qinghai Red Cross Hospital326 enrolled4 locationsNCT07423390
Recruiting
Phase 3
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
VomitingNausea
Affiliated Hospital of Qinghai University222 enrolled1 locationNCT07208305
Recruiting
Phase 3
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines150 enrolled64 locationsNCT06970743
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
bone metastasisPSMA PETProstate Cancer (Diagnosis)+4 more
Xijing Hospital1,000 enrolled9 locationsNCT07553754
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Treatment ResponseHigh-risk Prostate CancerPSMA PET+1 more
Xijing Hospital110 enrolled9 locationsNCT07553780
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled286 locationsNCT06764875
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Molecular ImagingSuspected Prostate CancerTreatment-naive Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07531329
Recruiting
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Clinically Significant Prostate Cancer
Xijing Hospital1,700 enrolled10 locationsNCT07492927
Recruiting
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital1,000 enrolled9 locationsNCT07474142
Recruiting
Not Applicable
68Ga-PSMA PET in the Renal Cell Carcinoma
MetastasesRenal CancerPSMA PET
Xijing Hospital300 enrolled9 locationsNCT04987086
Recruiting
Not Applicable
Hyperkalemia Quality Improvement Program (HK-QIP) Study
Hyperkalemia
AstraZeneca1,000 enrolled49 locationsNCT06884267
Recruiting
Phase 3
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006
Recruiting
Not Applicable
Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy
Breast CancerQuality of Life (QOL)Chemotherapy+2 more
Jiuda Zhao192 enrolled1 locationNCT06601621
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled69 locationsNCT07047365
Recruiting
Not Applicable
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Osteoporotic Fractures
Peking Union Medical College Hospital2,478 enrolled58 locationsNCT05866029
Recruiting
Phase 3
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
Congenital Hemophilia A
CSL Behring60 enrolled20 locationsNCT06738485
Recruiting
Phase 3
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer
Standard Quadruple Antiemetic TherapyElectroacupunctureChemotherapy-induced Gastrointestinal Symptom Cluster
Jiuda Zhao388 enrolled1 locationNCT06952920
Recruiting
Not Applicable
Indomethacin vs Diclofenac for Preventing PEP
PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441